Unity Biotechnology, Inc.

Ticker UBX

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

51-200 Employees
Based in South San Francisco, California

Unity Biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases.

Visit website

REPORT RATINGS

4.8 / 5.0 (187)

Unity Biotechnology, Inc. reports have an aggregate usefulness score of 4.8 based on 187 reviews.

Unity Biotechnology, Inc.